Market revenue in 2023 | USD 2,136.3 million |
Market revenue in 2030 | USD 3,368.7 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Polyphenylsulfone (ppsu) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyphenylsulfone (PPSU), Polyethersulfone (PES), Polyethylenimine (PEI), Polymethyl Methacrylate (PMMA) |
Key market players worldwide | Röchling Group, Nolato AB Class B, Compagnie de Saint-Gobain SA, SABIC, Orthoplastics, Eastman Chemical Co, Celanese Corp Class A, Dow Inc, Tekni-Plex, Solvay SA, Hmc Polymers Company, Integer Holdings Corp, Trelleborg AB ADR, Avantor Inc, Trinseo PLC, Evonik Industries AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical plastic market will help companies and investors design strategic landscapes.
Polyphenylsulfone (ppsu) was the largest segment with a revenue share of 57.96% in 2023. Horizon Databook has segmented the Canada medical plastic market based on polyethylene (pe), polypropylene (pp), polycarbonate (pc), liquid crystal polymer (lcp), polyphenylsulfone (ppsu), polyethersulfone (pes), polyethylenimine (pei), polymethyl methacrylate (pmma) covering the revenue growth of each sub-segment from 2018 to 2030.
Canada has one of the most stringent requirements in the world for medical devices. The Medical Devices Bureau of the Therapeutic Products Directorate (TPD) is the regulating body that monitors and evaluates the safety, effectiveness, and quality of medical devices.
Class II, III, or IV medical devices in Canada require a Canadian Medical Device License (MDL). Medical devices of Class II and above should qualify Medical Device Single Audit Program (MDSAP) to obtain a medical device license.
In terms of volume, Canada medical plastics market is expected to grow at a CAGR of 6.1% from 2023 to 2030. Healthcare industry is attracting significant investments in both the public and private sectors.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada medical plastic market , including forecasts for subscribers. This country databook contains high-level insights into Canada medical plastic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account